Genosis has held discussions with ten agencies to promote its first product, Fertell, across the trade, consumer and professional media. It expects to confirm the hire in around two months.
Fertell is an over-the-counter diagnostic test that aims to help couples monitor their fertility and improve the chances of conception.
US-based Genosis was established in 1998 and operates in the UK through a wholly owned subsidiary.
It has obtained Food and Drug Administration approval for the female device, while the male version's performance is under evaluation in the US and Europe. Fertell's UK launch is likely to be in the second half of this year.